BackClarity Pharmaceuticals Overview

Clarity Pharmaceuticals Common Stock

Latest common stock for CU6.AX: $450M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$450.96M
↑ 76.24% YoYΔ $195.08M vs prior year quarter

Peer trimmed avg / median

Loading

Clarity Pharmaceuticals Common Stock History

Loading

Clarity Pharmaceuticals vs. peers: Common Stock Comparison

Loading

Clarity Pharmaceuticals Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Clarity Pharmaceuticals (CU6.AX) FAQ

The latest common stock for CU6.AX is $450M as of June 2026. That compares with $260M in the prior-year period — up 76.2% year over year. Investors often review this figure alongside Clarity Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, CU6.AX's common stock moved from $260M to $450M — a 76.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Clarity Pharmaceuticals's operating scale or balance-sheet position.

A common stock figure of $450M for CU6.AX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CU6.AX's common stock ($450M), review year-over-year change from $260M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers